From: High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational study
Efficacy
Long-term
administration
( n = 11)
Intermediate-term
( n = 16)
Short-term
( n = 55)
Cycles
6.1 ± 8.5
5.6 ± 3.2
6.2 ± 8.3
PFS (month)
5.5 ± 6.9
3.8 ± 2.7
3.4 ± 4.4